| Dr Paula A Neuman, EDD, PSYD, HSPP | |
|
750 Broadway Ste 350, Fort Wayne, IN 46802-1412 | |
| (260) 423-2675 | |
| (260) 423-6621 |
| Full Name | Dr Paula A Neuman |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 13 Years |
| Location | 750 Broadway Ste 350, Fort Wayne, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144555855 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TH0100X | Psychologist - Health Service | 20042473A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nicolet Counseling Llc | 3173799731 | 2 |
| Neighborhood Health Clinics Inc | 8022926294 | 21 |
News Archive
Vienna, Austria: Men with prostate cancer that is small and confined to the prostate gland but that is at risk of growing and spreading, do better if they are treated with radiotherapy combined with androgen deprivation therapy, which lowers their levels of the male hormone, testosterone, according to new research.
Isis Pharmaceuticals, Inc. announced today that it has earned a $10 million milestone payment from Biogen Idec related to the initiation of investigational new drug (IND)-supporting studies of ISIS-BIIB3Rx. ISIS-BIIB3Rx is a recently identified development candidate designed to inhibit an undisclosed target to treat a neurodegenerative disease.
Genentech, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Avastin (bevacizumab) plus interferon-alfa for people with metastatic renal cell carcinoma, the most common type of kidney cancer. According to the American Cancer Society, kidney cancer is the eighth most commonly diagnosed cancer in the United States. In 2009, approximately 13,000 Americans will die from the disease.
Researchers at McGill University and the affiliated Lady Davis Institute for Medical Research at Montreal's Jewish General Hospital - along with colleagues at the University of Manitoba and the University of British Columbia - may have found a chink in the armour of the human immunodeficiency virus type 1 (HIV-1), the microorganism which causes AIDS. They have pinpointed the key cellular machinery co-opted by HIV-1 to hijack the human cell for its own benefit.
› Verified 8 days ago
| Entity Name | Neighborhood Health Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548291222 PECOS PAC ID: 8022926294 Enrollment ID: O20051012000658 |
News Archive
Vienna, Austria: Men with prostate cancer that is small and confined to the prostate gland but that is at risk of growing and spreading, do better if they are treated with radiotherapy combined with androgen deprivation therapy, which lowers their levels of the male hormone, testosterone, according to new research.
Isis Pharmaceuticals, Inc. announced today that it has earned a $10 million milestone payment from Biogen Idec related to the initiation of investigational new drug (IND)-supporting studies of ISIS-BIIB3Rx. ISIS-BIIB3Rx is a recently identified development candidate designed to inhibit an undisclosed target to treat a neurodegenerative disease.
Genentech, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Avastin (bevacizumab) plus interferon-alfa for people with metastatic renal cell carcinoma, the most common type of kidney cancer. According to the American Cancer Society, kidney cancer is the eighth most commonly diagnosed cancer in the United States. In 2009, approximately 13,000 Americans will die from the disease.
Researchers at McGill University and the affiliated Lady Davis Institute for Medical Research at Montreal's Jewish General Hospital - along with colleagues at the University of Manitoba and the University of British Columbia - may have found a chink in the armour of the human immunodeficiency virus type 1 (HIV-1), the microorganism which causes AIDS. They have pinpointed the key cellular machinery co-opted by HIV-1 to hijack the human cell for its own benefit.
› Verified 8 days ago
| Entity Name | Nicolet Counseling Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346535754 PECOS PAC ID: 3173799731 Enrollment ID: O20120103000196 |
News Archive
Vienna, Austria: Men with prostate cancer that is small and confined to the prostate gland but that is at risk of growing and spreading, do better if they are treated with radiotherapy combined with androgen deprivation therapy, which lowers their levels of the male hormone, testosterone, according to new research.
Isis Pharmaceuticals, Inc. announced today that it has earned a $10 million milestone payment from Biogen Idec related to the initiation of investigational new drug (IND)-supporting studies of ISIS-BIIB3Rx. ISIS-BIIB3Rx is a recently identified development candidate designed to inhibit an undisclosed target to treat a neurodegenerative disease.
Genentech, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Avastin (bevacizumab) plus interferon-alfa for people with metastatic renal cell carcinoma, the most common type of kidney cancer. According to the American Cancer Society, kidney cancer is the eighth most commonly diagnosed cancer in the United States. In 2009, approximately 13,000 Americans will die from the disease.
Researchers at McGill University and the affiliated Lady Davis Institute for Medical Research at Montreal's Jewish General Hospital - along with colleagues at the University of Manitoba and the University of British Columbia - may have found a chink in the armour of the human immunodeficiency virus type 1 (HIV-1), the microorganism which causes AIDS. They have pinpointed the key cellular machinery co-opted by HIV-1 to hijack the human cell for its own benefit.
› Verified 8 days ago
| Entity Name | Ne Psychological Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457998007 PECOS PAC ID: 6305270729 Enrollment ID: O20191218000723 |
News Archive
Vienna, Austria: Men with prostate cancer that is small and confined to the prostate gland but that is at risk of growing and spreading, do better if they are treated with radiotherapy combined with androgen deprivation therapy, which lowers their levels of the male hormone, testosterone, according to new research.
Isis Pharmaceuticals, Inc. announced today that it has earned a $10 million milestone payment from Biogen Idec related to the initiation of investigational new drug (IND)-supporting studies of ISIS-BIIB3Rx. ISIS-BIIB3Rx is a recently identified development candidate designed to inhibit an undisclosed target to treat a neurodegenerative disease.
Genentech, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Avastin (bevacizumab) plus interferon-alfa for people with metastatic renal cell carcinoma, the most common type of kidney cancer. According to the American Cancer Society, kidney cancer is the eighth most commonly diagnosed cancer in the United States. In 2009, approximately 13,000 Americans will die from the disease.
Researchers at McGill University and the affiliated Lady Davis Institute for Medical Research at Montreal's Jewish General Hospital - along with colleagues at the University of Manitoba and the University of British Columbia - may have found a chink in the armour of the human immunodeficiency virus type 1 (HIV-1), the microorganism which causes AIDS. They have pinpointed the key cellular machinery co-opted by HIV-1 to hijack the human cell for its own benefit.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paula A Neuman, EDD, PSYD, HSPP 750 Broadway Ste 350, Fort Wayne, IN 46802-1412 Ph: (260) 423-2675 | Dr Paula A Neuman, EDD, PSYD, HSPP 750 Broadway Ste 350, Fort Wayne, IN 46802-1412 Ph: (260) 423-2675 |
News Archive
Vienna, Austria: Men with prostate cancer that is small and confined to the prostate gland but that is at risk of growing and spreading, do better if they are treated with radiotherapy combined with androgen deprivation therapy, which lowers their levels of the male hormone, testosterone, according to new research.
Isis Pharmaceuticals, Inc. announced today that it has earned a $10 million milestone payment from Biogen Idec related to the initiation of investigational new drug (IND)-supporting studies of ISIS-BIIB3Rx. ISIS-BIIB3Rx is a recently identified development candidate designed to inhibit an undisclosed target to treat a neurodegenerative disease.
Genentech, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Avastin (bevacizumab) plus interferon-alfa for people with metastatic renal cell carcinoma, the most common type of kidney cancer. According to the American Cancer Society, kidney cancer is the eighth most commonly diagnosed cancer in the United States. In 2009, approximately 13,000 Americans will die from the disease.
Researchers at McGill University and the affiliated Lady Davis Institute for Medical Research at Montreal's Jewish General Hospital - along with colleagues at the University of Manitoba and the University of British Columbia - may have found a chink in the armour of the human immunodeficiency virus type 1 (HIV-1), the microorganism which causes AIDS. They have pinpointed the key cellular machinery co-opted by HIV-1 to hijack the human cell for its own benefit.
› Verified 8 days ago
Amanda L Mayle, PSY.D., HSPP Psychologist Medicare: Medicare Enrolled Practice Location: 11141 Parkview Plaza Dr Ste 210, Fort Wayne, IN 46845 Phone: 260-266-5400 Fax: 260-266-5409 | |
Dr. Michelle Renne Miller, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4630 W Jefferson Blvd, Ste 11a, Fort Wayne, IN 46804 Phone: 260-434-1606 Fax: 260-434-1612 | |
Dr. Victor L Rebman, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1910 Saint Joe Center Rd, Office #63, Fort Wayne, IN 46825 Phone: 260-471-9902 Fax: 260-471-9902 | |
Jason T. Cook, PSY.D., HSPP Psychologist Medicare: Accepting Medicare Assignments Practice Location: 7230 Engle Rd, Ste 304, Fort Wayne, IN 46804 Phone: 260-483-2400 Fax: 260-960-9361 | |
Dr. Galen Arthur Yordy, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2805 Fairfield Ave, Fort Wayne, IN 46807 Phone: 260-456-4880 Fax: 260-456-3559 | |
Dr. Kelly Stewart Hutner, PSY.D., HSPP Psychologist Medicare: Accepting Medicare Assignments Practice Location: 11143 Parkview Plaza Dr Ste 320, Fort Wayne, IN 46845 Phone: 260-266-5370 Fax: 260-266-5379 | |
Dr. Bruce Edward Nerenberg, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 2121 Lake Ave, Fort Wayne, IN 46805 Phone: 800-360-8387 Fax: 260-460-1481 |